These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1897022)

  • 1. The increased risk of fatal liver disease in renal transplant patients who are hepatitis Be antigen and/or HBV DNA positive.
    Fairley CK; Mijch A; Gust ID; Nichilson S; Dimitrakakis M; Lucas CR
    Transplantation; 1991 Sep; 52(3):497-500. PubMed ID: 1897022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of hepatitis B virus DNA in anti-HBe positive sera on longitudinal follow-up of patients with renal transplants and chronic hepatitis B.
    Norder H; Brattström C; Magnius L
    J Med Virol; 1989 Apr; 27(4):322-8. PubMed ID: 2656911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B disease in dialysis and transplant patients. Further epidemiologic and serologic studies.
    Harnett JD; Zeldis JB; Parfrey PS; Kennedy M; Sircar R; Steinmann TI; Guttmann RD
    Transplantation; 1987 Sep; 44(3):369-76. PubMed ID: 2820093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of renal transplantation in hepatitis B surface antigen-positive patients in cyclosporin era.
    Yagisawa T; Toma H; Tanabe K; Ishikawa N; Tokumoto N; Iguchi Y; Goya N; Nakazawa H; Takahashi K; Ota K
    Am J Nephrol; 1997; 17(5):440-4. PubMed ID: 9382163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: a regression analysis of indicators of risk.
    Craxì A; Tinè F; Vinci M; Almasio P; Cammà C; Garofalo G; Pagliaro L
    Am J Epidemiol; 1991 Sep; 134(6):641-50. PubMed ID: 1951268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
    Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayiannis A; Sjogren MH; Engle R; Karpodini E; Purcell RH
    Hepatogastroenterology; 1986 Aug; 33(4):151-4. PubMed ID: 3758906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hepatitis B and hepatitis C virus infection on the outcome of kidney transplantation.
    Yuan CH; Liu YF; Li GC
    Chin Med Sci J; 2005 Jun; 20(2):129-32. PubMed ID: 16075755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome.
    Heidrich B; Serrano BC; Idilman R; Kabaçam G; Bremer B; Raupach R; Önder FO; Deterding K; Zacher BJ; Taranta A; Bozkaya H; Zachou K; Tillmann HL; Bozdayi AM; Manns MP; Yurdaydın C; Wedemeyer H
    Liver Int; 2012 Oct; 32(9):1415-25. PubMed ID: 22716112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
    Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
    Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology.
    Stroffolini T; Sagnelli E; Rapicetta M; Felaco FM; Filippini P; Annella T; Petruzziello A; Chionne P; Sarrecchia B; Piccinino F
    Hepatogastroenterology; 1992 Feb; 39(1):62-5. PubMed ID: 1568710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization.
    Sawyer RG; McGory RW; Gaffey MJ; McCullough CC; Shephard BL; Houlgrave CW; Ryan TS; Kuhns M; McNamara A; Caldwell SH; Abdulkareem A; Pruett TL
    Ann Surg; 1998 Jun; 227(6):841-50. PubMed ID: 9637547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of renal transplantation in hepatitis B surface antigen-positive patients after introduction of lamivudine.
    Park SK; Yang WS; Lee YS; Jung HH; Chang JW; Choi HJ; Han DJ; Park JS
    Nephrol Dial Transplant; 2001 Nov; 16(11):2222-8. PubMed ID: 11682671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. A prospective study of 90 patients.
    Degos F; Lugassy C; Degott C; Debure A; Carnot F; Theirs V; Tiollais P; Kreis H; Brechot C
    Gastroenterology; 1988 Jan; 94(1):151-6. PubMed ID: 3275563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBV DNA and other hepatitis B virus markers in sera from long-term hemodialysis and kidney transplant patients.
    Theilmann L; Gmelin K; Rambausek M; Dreikorn K; Bommer J; Kommerell B; Pfaff E
    Hepatogastroenterology; 1988 Aug; 35(4):147-50. PubMed ID: 3053386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
    Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients.
    Huo TI; Yang WC; Wu JC; King KL; Loong CC; Lin CY; Lui WY; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):93-100. PubMed ID: 10677918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B inactive carriers: clinical course and outcomes.
    Tong MJ; Trieu J
    J Dig Dis; 2013 Jun; 14(6):311-7. PubMed ID: 23433008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus DNA in hepatitis B surface antigen-positive blood donors: relation to the hepatitis B e system and outcome in recipients.
    Krogsgaard K; Wantzin P; Aldershvile J; Kryger P; Andersson P; Nielsen JO
    J Infect Dis; 1986 Feb; 153(2):298-303. PubMed ID: 3944482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.
    Bonino F; Rosina F; Rizzetto M; Rizzi R; Chiaberge E; Tardanico R; Callea F; Verme G
    Gastroenterology; 1986 May; 90(5 Pt 1):1268-73. PubMed ID: 3956945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.